Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin

Figure 3

Comparison of YB-1/p18 with established tumor markers in patients with various malignancies. (A) Positivity of YB-1/p18 and other available tumor markers for the total cohort of patients with malignant disorders. (B-D) Positivity of YB-1/p18 in comparison to the most sensitive of the other tested markers for patients with lung cancer (B), breast cancer (C), or other solid tumors (D). The number of patients in which the respective markers were assessed is given. Abbreviations are used as in the main text. Cut-off values for the established tumor markers are given in the Methods’ section.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us